Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale

被引:361
作者
Mennin, DS
Fresco, DM
Heimberg, RG
Schneier, FR
Davies, SO
Liebowitz, MR
机构
[1] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[3] Columbia Univ, New York, NY USA
关键词
Liebowitz Social Anxiety Scale; social anxiety disorder; clinical settings;
D O I
10.1016/S0887-6185(02)00134-2
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: We sought to determine optimal cutoff values for the Liebowitz Social Anxiety Scale (LSAS) total and subscale scores for the diagnosis of social anxiety disorder (SAD) and designation of the generalized subtype of SAD. Method: Three hundred and sixty-four patients from a multi-site sample who met criteria for SAD according to structured diagnostic interview, 262 of whom met criteria for the generalized subtype, and 34 control participants free of current Axis I disorders participated in this study. All participants were given the Liebowitz Social Anxiety Scale by an independent assessor. Results: Receiver Operating Characteristics analysis revealed that the LSAS performed well in identifying individuals who met criteria for SAD and for the generalized subtype of SAD. Cutoffs of 30 for SAD and 60 for its generalized subtype on the LSAS total score represented the best balance of specificity and sensitivity. Conclusions: These findings provide support for the use of the Liebowitz Social Anxiety Scale for the identification of individuals with SAD and its generalized subtype in clinical settings. Identification of patients with SAD should increase the percentage of these patients who receive appropriate treatment for this impairing disorder. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:661 / 673
页数:13
相关论文
共 47 条
[1]   Quality of life in anxiety and social phobia [J].
Bech, P ;
Angst, J .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :97-100
[2]   Social phobia in primary care: Level of recognition and drug use [J].
Bisserbe, JC ;
Weiller, E ;
Boyer, P ;
Lepine, JP ;
Lecrubier, Y .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :25-28
[3]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[4]   SOCIAL PHOBIA SUBTYPE AND AVOIDANT PERSONALITY-DISORDER - EFFECT ON SEVERITY OF SOCIAL PHOBIA, IMPAIRMENT, AND OUTCOME OF COGNITIVE-BEHAVIORAL TREATMENT [J].
BROWN, EJ ;
HEIMBERG, RG ;
JUSTER, HR .
BEHAVIOR THERAPY, 1995, 26 (03) :467-486
[5]   Reliability of DSM-IV anxiety and mood disorders:: Implications for the classification of emotional disorders [J].
Brown, TA ;
Di Nardo, PA ;
Lehman, CL ;
Campbell, LA .
JOURNAL OF ABNORMAL PSYCHOLOGY, 2001, 110 (01) :49-58
[6]  
Di Nardo P.A., 1994, Anxiety Disorders Interview Schedule for DSM-IV
[7]  
Di Nardo P. A., 1988, Anxiety disorders interview schedule--revised (ADIS-R). Phobia and anxiety disorders clinic
[8]  
DINARDO PA, 1993, ARCH GEN PSYCHIAT, V50, P251
[9]  
First MB, 1996, STRUCTURED CLIN INTE
[10]  
GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO